fluticasone
UkraineDrugs containing this active substance
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of two types of active substances). It is used if standard therapy does not provide adequate symptom control or if the patient is already benefiting from combination treatment with different drugs.
Form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg per dose fluticasone 50 mcg/dose ATC: R03AK06
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of two types of active substances). It is used if standard therapy does not provide sufficient symptom control or if the patient is already benefiting from combination treatment using different drugs in separate inhalers.
Form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg per dose fluticasone 125 mcg/dose ATC: R03AK06
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
The drug is used to relieve the symptoms of moderate to severe seasonal and perennial allergic rhinitis if standard antihistamines or hormonal sprays are not effective.
Form: spray, nasal suspension
Active substance Dosage azelastine 137 mcg fluticasone 50 mcg ATC: R01AD58
Manufacturer: MEDA Pharma GmbH & Co. KG (manufacturer, responsible for batch release)
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children aged 16 years and older, as well as for the treatment of chronic obstructive pulmonary disease (COPD) in combination with another agent.
Form: powder for inhalation, hard capsules
Active substance Dosage fluticasone 125 mcg ATC: R03BA05
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children (from 16 years of age), as well as for the treatment of chronic obstructive pulmonary disease (COPD) in combination with another agent.
Form: powder for inhalation, hard capsules
Active substance Dosage fluticasone 250 mcg ATC: R03BA05
-
The drug is used to treat various skin diseases, such as atopic dermatitis, psoriasis, seborrheic dermatitis, lichen planus, insect bite reactions, erythema ab igne, and other corticosteroid-responsive dermatoses. In children from 3 months of age, it is prescribed for the treatment of atopic dermatitis if other less potent agents have failed.
Form: cream
Active substance Dosage fluticasone 0.5 mg/g ATC: D07AC17
Manufacturer: LLC "Pharmaceutical Company "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used to treat various skin diseases, such as atopic dermatitis, psoriasis, seborrheic dermatitis, lichen planus, insect bite reactions, erythema ab igne, and other corticosteroid-responsive dermatoses.
Form: ointment
Active substance Dosage fluticasone 0.05 mg/g ATC: D07AC17
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used for the prevention and treatment of seasonal and perennial allergic rhinitis (including hay fever).
Form: spray, nasal suspension
Active substance Dosage fluticasone 50 mcg/dose ATC: R01AD08
Manufacturer: Teva Czech Industries s.r.o.
-
The drug is used for the prevention and treatment of allergic rhinitis (including hay fever and reactions to dust mites or animal hair). It helps relieve sneezing, itching in the nose and eyes, runny nose, nasal congestion, and sinus discomfort.
Form: spray, nasal, aqueous, metered
Active substance Dosage fluticasone 50 mcg/dose ATC: R01AD08
Manufacturer: Glaxo Wellcome S.A. (manufacturing, quality control, batch release, primary and secondary packaging)
-
The drug is used for the regular treatment of bronchial asthma (if other methods do not provide sufficient control) and for maintenance therapy in chronic obstructive pulmonary disease (COPD).
Form: powder, inhalation, metered
Active substance Dosage salmeterol 50 mcg/dose fluticasone 250 mcg/dose ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The drug is used for the regular treatment of bronchial asthma and maintenance therapy for chronic obstructive pulmonary disease (COPD).
Form: powder, inhalation, metered
Active substance Dosage salmeterol 50 mcg/dose fluticasone 500 mcg/dose ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of a long-acting bronchodilator and an inhaled corticosteroid).
Form: aerosol, metered for inhalation
Active substance Dosage salmeterol 25 mcg per dose fluticasone 50 mcg/dose ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of a long-acting bronchodilator and an inhaled corticosteroid).
Form: aerosol, metered for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 250 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of long-acting active substances and corticosteroids).
Form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 125 mcg ATC: R03AK06
Manufacturer: Cipla Ltd. (Unit II)
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy with long-acting β2-adrenoceptor agonists and inhaled corticosteroids.
Form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 250 mcg ATC: R03AK06
Manufacturer: Cipla Ltd. (Unit II)
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy with long-acting β2-adrenoceptor agonists and inhaled corticosteroids.
Form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg fluticasone 50 mcg ATC: R03AK06
Manufacturer: Cipla Ltd. (Unit II)